EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Paving the way for bacteria-based drug delivery: biohybrid microrobots emerging from microrobotics and synthetic biology

Elena Totter, Emilie von Einsiedel, Lisa Regazzoni, Simone Schuerle

Advanced Drug Delivery Reviews · 2025-06 · 221 · 115577

DOI: 10.1016/j.addr.2025.115577 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2025-06. Verfasst von Elena Totter und 3 weiteren Autor:innen. Beteiligte Einrichtung: ETH Zurich, Institute of Translational Medicine, Gloriastrasse 37/39, 8092 Zurich, Switzerland. Hauptthemen laut MEDLINE: Synthetic Biology, Drug Delivery Systems, Robotics, Bacteria. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in microrobotics and synthetic biology are paving the way for innovative solutions to long-standing challenges in drug delivery. Both fields have independently worked on engineering bacteria as a therapeutic system, focusing on enhancing propulsion, cargo delivery, detection, and biocompatibility. Bacteria, with their inherent adaptability and functional versatility, serve as an ideal foundation for these efforts, enabling them to navigate complex biological environments such as the human body. This review explores the convergence of microrobotics and synthetic biology, which has catalysed the development of biohybrid bacterial microrobots that integrate the strengths of both disciplines. By incorporating external control modalities - such as light, ultrasound, and magnetic fields - these hybrid systems address the limitations of purely microrobotic or biological approaches, offering new opportunities to enhance precision and efficacy in targeted therapies. However, realising the full potential of biohybrid bacterial microrobots requires overcoming critical challenges, such as ensuring compatibility between biological and synthetic components, scaling manufacturing processes, and defining regulatory pathways tailored to living therapeutics. Addressing these hurdles through joint, interdisciplinary research efforts, can unlock the transformative possibilities of these systems in modern medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Synthetic BiologyDrug Delivery SystemsRoboticsBacteriaHumansAnimals

Stichwörter der Autor:innen

Bacteria-based microrobotsBiohybrid systemsMicroroboticsSynthetic microbiologyTargeted drug delivery

Autor:innen und Institutionen

  • ETH Zurich, Institute of Translational Medicine, Gloriastrasse 37/39, 8092 Zurich, Switzerland.
  • ETH Zurich, Institute of Translational Medicine, Gloriastrasse 37/39, 8092 Zurich, Switzerland. Electronic address: simone.schuerle@hest.ethz.ch.

Förderung

  • Swiss National Science Foundation

Zitieren

APA

Totter, E., von Einsiedel, E., Regazzoni, L., & Schuerle, S. (2025). Paving the way for bacteria-based drug delivery: biohybrid microrobots emerging from microrobotics and synthetic biology. Advanced Drug Delivery Reviews, 221, 115577. https://doi.org/10.1016/j.addr.2025.115577

Vancouver

Totter E, von Einsiedel E, Regazzoni L, Schuerle S. Paving the way for bacteria-based drug delivery: biohybrid microrobots emerging from microrobotics and synthetic biology. Advanced Drug Delivery Reviews. 2025;221:115577. doi:10.1016/j.addr.2025.115577

BibTeX
@article{Totter2025,
  author = {Totter, Elena and von Einsiedel, Emilie and Regazzoni, Lisa and Schuerle, Simone},
  title = {Paving the way for bacteria-based drug delivery: biohybrid microrobots emerging from microrobotics and synthetic biology},
  journal = {Advanced Drug Delivery Reviews},
  year = {2025},
  volume = {221},
  pages = {115577},
  doi = {10.1016/j.addr.2025.115577}
}
Kostenlos starten →